Lupin announced today the successful completion of an inspection carried out by the US FDA at its Nagpur, Maharashtra, India facility. The inspection concluded without any observation. This inspection was a product specific pre-approval inspection.
Lupin's Nagpur facility is the company's latestsite and manufactures Oral Solid Dosage products. The site also houses Lupin's state of the art injectable manufacturing facility.
Shares of LUPIN LTD. was last trading in BSE at Rs.956.35 as compared to the previous close of Rs. 939.6. The total number of shares traded during the day was 202127 in over 4876 trades.
The stock hit an intraday high of Rs. 960 and intraday low of 922. The net turnover during the day was Rs. 190861123.